Precision medicine is crucial to providing highly effective, high-value care to patients with serious diseases. Celgene CEO, Mark Alles, states he is committed to working with health care payers to improve access to precision medicines to patients who need them. Read more here.
Last Updated on May 13, 2020 by Aimed Alliance
